English
Back
Download
Log in to access Online Inquiry
Back to the Top

NEWS

VSee Health Secures Teleradiology Contract with Leading Post-Acute Care Hospital System
Thursday, 19th December at 8:30 am
VSee Health, Inc. (NASDAQ: VSEE), a leader in telehealth solutions, today announced the award of a teleradiology contract with one of the largest post-acute care hospital systems in the United States. This partnership, set to launch in Q1 of 2025, marks the latest addition to VSee's growing roster of teleradiology customers and reinforces its position as a trusted provider of advanced imaging solutions.
The initial rollout will include three hospital locations representing a potential $1.5 million in annual recurring revenue, with the contract structured to automatically renew annually. Through this collaboration, VSee aims to improve diagnostic accuracy, accelerate turnaround times for imaging results, and enhance patient outcomes through seamless, 24/7 radiology interpretations.
Highlights of VSee's Teleradiology Solutions:
Improved Diagnostic Efficiency: Real-time, remote interpretation of X-rays, MRIs, and CT scans, reducing delays in patient diagnosis and treatment initiation.
Enhanced Flexibility for Radiologists: VSee's technology enables radiologists to provide expertise from any location, ensuring round-the-clock coverage without disrupting workflow.
Customizable Cloud Clinic: VSee's platform allows integration with existing systems, facilitating smooth consultations, second opinions, and real-time collaboration with specialists.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
10K Views
Comment
Sign in to post a comment
    Spread kindness and love. Life is short. Don’t let greed eat you.
    8980
    Followers
    54
    Following
    107K
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.